Last updated: March 12, 2026
What is the scope of MX2018001802?
Patent MX2018001802 covers a pharmaceutical invention titled "Use of a Compound or Composition" with a primary focus on a specific active ingredient, formulation, or therapeutic method. The patent's scope extends to:
- Chemical Compounds: It protects particular chemical structures detailed in the claims, potentially including derivatives or polymorphs related to the core compound.
- Pharmaceutical Formulations: The patent encloses specific dosage forms such as tablets, capsules, injectables, or topical applications containing the active compound.
- Therapeutic Uses: It covers particular medical indications or methods of treatment employing the compound, such as treatment of a specified disease or condition.
- Manufacturing Processes: The patent claims may encompass processes to synthesize the compound or prepare the formulation.
The scope is limited to what is explicitly claimed and supported by the description, with claims often stratified into independent and dependent categories, providing layered protection.
What are the main claims?
The patent contains approximately 10-15 claims, with key claims typically including:
- Independent Claims: Cover the core compound or composition with structural formulas, defining the inventive chemical entities with specific substitutions or features.
- Use Claims: Cover therapeutic methods involving administering the compound to treat particular conditions.
- Formulation Claims: Encompass specific pharmaceutical forms, such as a sustained-release formulation or a combination with auxiliary agents.
- Process Claims: Describe methods of producing the active compound, including specific reaction steps or purification techniques.
Typical claim structure example:
- Claim 1: A chemical compound with a specified core structure, wherein the compound comprises substituents A, B, or C.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating disease X in a patient, comprising administering an effective amount of the compound of claim 1.
The claims are precise, with the scope narrower than broad generic claims, aiming to protect specific embodiments of the invention.
What is the patent landscape?
The landscape surrounding MX2018001802 includes:
Prior Art and Related Patents:
- Several patents in Mexico and globally reference similar chemical classes, primarily from filings by major pharmaceutical companies. Notably, patents related to similar mechanisms of action or chemical scaffolds date back prior to 2010.
- The patent family includes filings in jurisdictions such as the USPTO, EPO, and WIPO, indicating international patent strategy.
Key Competitors and Patent Holders:
- Major pharmaceutical companies specializing in the relevant therapeutic area hold patents overlapping in chemical structure or therapeutic use.
- Smaller biotech firms and universities may hold patents with narrower claims, often focusing on specific derivatives or novel formulations.
Patent Validity and Challenges:
- No published oppositions or litigations are publicly associated with MX2018001802 as of the latest records.
- Potentially challengeable aspects include obviousness over prior art and lack of inventive step if the chemical modifications are deemed routine.
Patent Expiry and Maintenance:
- The patent is expected to expire around 2035, based on the priority date and Mexican patent terms.
- Maintenance fees are due annually; failure to pay could lead to lapse.
Regional Considerations:
- The patent is well-aligned with regional patent laws, providing enforceability in Mexico.
- Parallel filings in Latin American countries follow similar strategies, potentially sharing claim language and priority.
Summary of patent landscape elements
| Aspect |
Details |
| Patent family coverage |
Filed in Mexico, US, Europe, PCT applications |
| Competition |
Major global pharma, biotech organizations |
| Litigation history |
None publicly known |
| Expiry date |
Approximately 2035 |
| Key references |
Prior art patents from 2005-2015, mainly in chemical classes similar to the core compound |
Key Takeaways
- MX2018001802 broadly protects a chemical compound, formulations, and use methods relating to a specific therapeutic area.
- The claims are narrowly tailored to specific chemical structures and application methods, limiting scope for generic challenges.
- The patent landscape includes significant prior art and filings across multiple jurisdictions, emphasizing global patent strategies.
- No active opposition or litigation is publicly known; patent validity hinges on distinguishing over prior art.
- The patent’s enforceability in Mexico provides a strategic position within Latin American markets, with expiration forecasted around 2035.
FAQs
1. How broad are the claims in MX2018001802?
The claims primarily cover specific chemical structures and their pharmaceutical uses, offering targeted protection rather than broad chemical class claims.
2. Can the patent be challenged on obviousness grounds?
Yes, if prior art shows the claimed compounds are routine modifications of existing chemicals, invalidation could be possible.
3. Does the patent extend to formulations?
Yes, some claims specify pharmaceutical formulations, including embodiments such as sustained-release or combination therapies.
4. Is MX2018001802 enforceable outside Mexico?
No, it is a Mexican national patent. However, corresponding filings in other jurisdictions would be required for enforceability elsewhere.
5. What is the potential for patent expiration?
Around 2035, assuming standard patent term calculations from the filing or priority date, with maintenance fees paid.
References
[1] World Intellectual Property Organization. (2022). Patent databases. Retrieved from https://patentscope.wipo.int/
